Skip to content
Trial Eligibility
Menu

Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD

NCT07382596

This study is recruiting at 4 US sites in 3 states, according to its ClinicalTrials.gov record last updated .

Summary

PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with an injection control of normal saline (NS)

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • PTSD

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
19 to 90 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Dr. Dean Reeves Clinic
Last updated on ClinicalTrials.gov
September 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Kentucky · 1

  • Wellward Medical · Lexington, KY

Oregon · 2

  • NW Regen · Portland, OR
  • Paul Johnson, MD. · Portland, OR

Wisconsin · 1

  • Medical Procedures of Wisconsin · Madison, WI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.